Medicare Enrolled

Dr. Patrick Win, M.D.

Allergy & Immunology · Shiloh, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
325 TAMARACK LN, Shiloh, IL 62269
6186242060
In practice since 2006 (19 years)
NPI: 1346335783 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Win from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Win? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Win

Dr. Patrick Win is an allergy & immunology specialist in Shiloh, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Win performed 25,901 Medicare services across 431 unique beneficiaries.

Between the years covered by Open Payments, Dr. Win received a total of $260,949 from 26 pharmaceutical and/or device companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Win is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in IL $260,949 industry payments

Medicare Practice Summary

Medicare Utilization ↗
25,901
Medicare services
Top 1% in IL for allergy & immunology
431
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,363 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 15,225 $30 $80
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
7,503 $11 $35
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
1,569 $8 $40
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
634 $3 $12
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
631 $11 $40
Injection for rapid desensitization to allergen 201 $107 $280
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
92 $93 $200
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
28 $28 $95
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $130 $280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$260,949
Total received (2018-2024)
Avg $37,278/year across 7 years
Top 1% in IL for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
494
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$228,136 (87.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$27,793 (10.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,020 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$63,879
2023
$29,209
2022
$17,408
2021
$11,911
2020
$41,683
2019
$57,204
2018
$39,655

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$63,592
Amgen Inc.
$203
PFIZER INC.
$31
Kedrion Biopharma, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
Lundbeck LLC
$14
Top 3 companies account for 99.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$150,279
Genentech USA, Inc.
$73,163
GlaxoSmithKline, LLC.
$12,447
Novartis Pharmaceuticals Corporation
$8,026
Genentech, Inc.
$7,771
Regeneron Healthcare Solutions, Inc.
$5,017
GENZYME CORPORATION
$1,029
Amgen Inc.
$905
Teva Pharmaceuticals USA, Inc.
$677
Takeda Pharmaceuticals U.S.A., Inc.
$430
OptiNose US, Inc.
$406
Janssen Pharmaceuticals, Inc
$202
Shire North American Group Inc
$194
Kaleo, Inc.
$111
PFIZER INC.
$59
AbbVie Inc.
$38
BioCryst US Sales Co., LLC
$27
Horizon Therapeutics plc
$25
Optinose US, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$22
Octapharma USA, Inc.
$21
Kedrion Biopharma, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
IMPEL PHARMACEUTICALS INC.
$15
Lundbeck LLC
$14
BioCryst Pharmaceuticals, Inc.
$14
Top 3 companies account for 90.4% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · AIRSUPRA · Albuked · Auvi-Q · BOTOX · BREO · BREZTRI · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dysport · EUCRISA · FASENRA · HYQVIA · NUCALA · ORLADEYO · PANZYGA · ProAir Digihaler · SPRAVATO · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · Trudhesa · VYEPTI · XIIDRA · XOLAIR · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for allergy & immunology in IL.

Looking for an allergy & immunology specialist in Shiloh?
Compare allergy & immunologists in the Shiloh area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
8
Per 100K population
3.1
County median income
$70,178
Nearest hospital
HSHS ST ELIZABETH'S HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Win is a mixed practice specialist, with above-average Medicare volume (top 1% in IL), with speaking/promotional industry engagement in the top 1% of IL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Win experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Win performed 15,225 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Win receive payments from pharmaceutical companies?
Yes. Dr. Win received a total of $260,949 from 26 companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Win's costs compare to other allergy & immunologists in Shiloh?
Dr. Win's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Win) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →